| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
11,512,800 | 11,245,200 | 11,098,400 | 10,952,300 | 10,906,700 |
| Cost of Revenue
|
-9,842,500 | -4,757,100 | -4,829,900 | -5,054,300 | -5,332,300 |
|
Gross Profit
|
1,670,300 | 6,488,100 | 6,268,500 | 5,898,000 | 5,574,400 |
| Selling, General and Administrative Expenses
|
-4,873,500 | -4,873,500 | -4,767,000 | -4,430,100 | -4,283,500 |
|
Research and Development Expenses
|
-18,000 | -- | -18,000 | -- | -- |
| Depreciation, Amortization and Depletion
|
-338,900 | -319,900 | -292,200 | -269,400 | -259,300 |
| Other Income/Expense, Operating
|
41,400 | 41,400 | 39,600 | 50,000 | 45,000 |
|
Operating Income/Expenses
|
-338,900 | -5,152,000 | -5,019,600 | -4,649,500 | -4,497,800 |
|
Total Operating Profit/Loss
|
1,331,400 | 1,336,100 | 1,248,900 | 1,248,500 | 1,076,600 |
| Total Net Finance Income/Expense
|
1,000 | -9,900 | 2,500 | 8,900 | 17,300 |
| Net Investment Income
|
-1,700 | 500 | 2,700 | -2,900 | -20,000 |
| Irregular Income/Expenses
|
-36,000 | -- | -36,000 | -48,300 | -45,400 |
|
Non-Operating Income/Expenses, Total
|
-700 | -9,400 | 5,200 | -42,300 | -48,100 |
|
Pretax Income
|
1,330,600 | 1,326,800 | 1,254,100 | 1,206,100 | 1,028,400 |
|
Provision for Income Tax
|
-331,000 | -334,800 | -293,100 | -274,600 | -244,000 |
|
Net Income from Continuing Operations
|
999,600 | 992,000 | 961,000 | 931,500 | 784,400 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
999,600 | 991,900 | 961,000 | 931,600 | 784,500 |
|
Non-Controlling/Minority Interests
|
-12,000 | -11,900 | -9,700 | -5,800 | -10,000 |
|
Net Income after Non-Controlling/Minority Interests
|
987,600 | 980,100 | 951,300 | 925,800 | 774,500 |
|
Net Income Available to Common Stockholders
|
987,600 | 980,100 | 951,300 | 925,800 | 774,500 |
|
Diluted Net Income Available to Common Stockholders
|
987,600 | 980,100 | 951,300 | 925,800 | 774,500 |
|
Common Dividend per Share
|
1.80 | 1.80 | 1.80 | 1.75 | 1.75 |
| Basic EPS
|
1.91 | 1.89 | 1.84 | 1.79 | 1.50 |
| Diluted EPS
|
1.90 | 1.89 | 1.84 | 1.79 | 1.49 |
|
Basic Weighted Average Shares Outstanding
|
516,311.03 | 517,810 | 517,501 | 517,217 | 517,841 |
|
Diluted Weighted Average Shares Outstanding
|
520,397.30 | 519,087 | 518,014 | 517,595 | 518,164 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,329,600 | 1,331,200 | 1,248,000 | 1,191,900 | 1,004,800 |
|
EBITDA
|
1,668,500 | 1,651,100 | 1,540,200 | 1,461,300 | 1,264,100 |
|
Normalized EBITDA
|
1,668,500 | 1,651,100 | 1,540,200 | 1,509,600 | 1,309,500 |
12/31/2022 - 1/17/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade